PARATEK PHARMACEUTICALS INC (PRTK)
US6993743029 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -62.73M | -63.57M | -59.08M | -96.54M | -128.79M | |||
| Depreciation Amortization | 308.00K | 490.00K | 391.00K | 580.00K | N/A | |||
| Change In Working Capital | 23.96M | -20.79M | -8.19M | -20.29M | -21.74M | |||
| Interest Paid | 12.96M | 11.91M | 13.14M | 22.70M | 15.96M | |||
| Other non cash items | 15.24M | 17.73M | 18.61M | 12.83M | 16.48M | |||
| OPERATING CASH FLOW | -23.22M | -66.14M | -48.27M | -103.42M | -134.05M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -32.00K | -36.00K | -373.00K | -380.00K | -240.00K | |||
| Other Investing Activity | 30.00M | 14.84M | 4.88M | 92.88M | 134.79M | |||
| INVESTING CASH FLOW | 29.97M | 14.80M | 4.51M | 92.50M | 134.55M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.73M | -2.89M | -716.00K | -11.28M | 30.55M | |||
| Stock Issued/Repurchased | -483.00K | 7.33M | 19.05M | 22.62M | 27.07M | |||
| Other Financing Activity | N/A | 646.00K | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -3.57M | 5.09M | 18.33M | 11.34M | 57.62M | |||
| CHANGE IN CASH | 3.18M | -46.24M | -25.43M | 420.00K | 58.12M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -23.22M | -66.14M | -48.27M | -103.42M | -134.05M | |||
| Capital Expenditure | -32.00K | -36.00K | -373.00K | -380.00K | -240.00K | |||
| FREE CASH FLOW | -23.25M | -66.18M | -48.65M | -103.80M | -134.29M | |||
All data in USD